Bank Of New York Mellon Corp Zentalis Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $2.86 Million - $4.05 Million	158,185 New	158,185 $3.19 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $696,498 - $1.09 Million	34,429 Added 29.08%	152,808 $3.31 Million
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $451,761 - $1.32 Million	-25,224 Reduced 17.57%	118,379 $3.33 Million
Q1 2022 May 11, 2022	SELL	$41.58 - $80.89 $1,039 - $2,022	-25 Reduced 0.02%	143,603 $6.63 Million
Q4 2021 Feb 11, 2022	BUY	$66.92 - $84.79 $334,666 - $424,034	5,001 Added 3.61%	143,628 $12.1 Million
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $2.05 Million - $3.22 Million	43,779 Added 46.16%	138,627 $9.24 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $188,808 - $314,175	5,047 Added 5.62%	94,848 $5.05 Million
Q1 2021 May 13, 2021	SELL	$35.69 - $52.72 $243,441 - $359,603	-6,821 Reduced 7.06%	89,801 $3.9 Million
Q4 2020 Feb 09, 2021	BUY	$31.71 - $57.97 $2.01 Million - $3.67 Million	63,303 Added 189.99%	96,622 $5.02 Million
Q3 2020 Nov 12, 2020	BUY	$27.03 - $47.97 $58,303 - $103,471	2,157 Added 6.92%	33,319 $1.09 Million
Q2 2020 Aug 12, 2020	BUY	$23.2 - $54.8 $722,958 - $1.71 Million	31,162 New	31,162 $1.5 Million

140

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $108M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.